Studies using the NAFLD model also highlighted the importance of IL-13 in the liver by showing that IL-13 was involved in progression from simple steatosis to metabolic-disfunction-associated steatohepatitis (for a review, see [40]). This evidence concerns the gene IL13 and metabolic dysfunction-associated steatotic liver disease.